Ian L. Turner

Board Member: Non-Executive Director at RadioPharm Theranostics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Graduate Diploma of Company Director
    -

Experience

  • Radiopharm Theranostics
    • Australia
    • Biotechnology Research
    • 1 - 100 Employee
    • Board Member: Non-Executive Director
      • Apr 2021 - Present

      Non-Executive Director at RadioPharm Theranostics. The company has a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses. Non-Executive Director at RadioPharm Theranostics. The company has a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.

  • AtomVie Global Radiopharma Inc.
    • Canada
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Board Member: Non-Executive Director
      • Aug 2022 - Present

      Non-Executive Director at AtomVie. Leveraging over ten years of expertise in the GMP manufacturing and global distribution of radiopharmaceuticals, the Centre for Probe Development and Commercialization (CPDC) is launching AtomVie Global Radiopharma Inc. (AtomVie), a global leading Contract Development and Manufacturing Organization (CDMO). AtomVie empowers next-generation radiotherapeutics and thrives to support its partners from early clinical development to commercial manufacturing. AtomVie offers the full range of scientific, technical, regulatory, quality, logistics and business expertise combined with a specialized infrastructure for the development of your radiotherapeutics from Phase 1 to the commercial marketplace. AtomVie has in-depth experience in radiopharmaceutical manufacturing, including expertise in radiolabeling with an array of radioisotopes such as Lu-177, Ac-225, I-131 and ligands that range from small molecules, to peptides to small and large antibodies.

  • TURNER GROUP: Multinational Corp. Executive | M&A | Change Manager | Team Builder | Corp. Strategist
    • United States
    • Executive Consultant & CEO
      • 2013 - Present

      The TURNER GROUP provides Executive Management consulting services to Institutional Investors such as private equity firm Warburg Pincus, Bain Capital and more. We also work with global consulting firms such as Gerson Lehrman Group, Guidepoint Global, L.E.K. Consulting, IQ4I etc. We can assist you with your understanding and/or due diligence on acquisition targets in the field of Nuclear Medicine, Radiochemicals & Radiopharmaceuticals. The TURNER GROUP provides Executive Management consulting services to Institutional Investors such as private equity firm Warburg Pincus, Bain Capital and more. We also work with global consulting firms such as Gerson Lehrman Group, Guidepoint Global, L.E.K. Consulting, IQ4I etc. We can assist you with your understanding and/or due diligence on acquisition targets in the field of Nuclear Medicine, Radiochemicals & Radiopharmaceuticals.

  • IQ4I Research and Consultancy Pvt. Ltd.
    • India
    • Market Research
    • 1 - 100 Employee
    • Advisory Board Member
      • Apr 2016 - Present

      IQ4I is a global strategy, consulting and a leading market research company. Its clients include leading businesses, investment banks, researchers and government agencies. They are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. They enable their clients to identify the market opportunities with best-in-class market intelligence reports. IQ4I is a global strategy, consulting and a leading market research company. Its clients include leading businesses, investment banks, researchers and government agencies. They are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. They enable their clients to identify the market opportunities with best-in-class market intelligence reports.

  • East Tennessee Economic Council (ETEC)
    • United States
    • Non-profit Organizations
    • 1 - 100 Employee
    • Board Member
      • Jan 2019 - Dec 2021

      ETEC is an independent, regional, non-profit, membership organization created in the early 1970s, dedicated to supporting the federal government’s missions in East Tennessee, as well as seeking new ways to create prosperity, promote regional development, and explore opportunities for growth. See https://eteconline.org/ ETEC is an independent, regional, non-profit, membership organization created in the early 1970s, dedicated to supporting the federal government’s missions in East Tennessee, as well as seeking new ways to create prosperity, promote regional development, and explore opportunities for growth. See https://eteconline.org/

  • Coquí RadioPharmaceuticals
    • Oak Ridge, TN
    • Board Member
      • Nov 2014 - Mar 2019

      Member of the Company Board at Coquí RadioPharmaceuticals. Coquí RadioPharmaceuticals, Corp. (Coquí Pharma) is a company whose mission is to create a commercially scalable and reliable supply of medical diagnostic and therapeutic radioisotopes in the United States using Low Enriched Uranium [LEU]. The new state of the art facility in Oak Ridge, TN will incorporate two nuclear reactors and multiple radiopharmaceutical production facilities. See www.coquipharma.com Member of the Company Board at Coquí RadioPharmaceuticals. Coquí RadioPharmaceuticals, Corp. (Coquí Pharma) is a company whose mission is to create a commercially scalable and reliable supply of medical diagnostic and therapeutic radioisotopes in the United States using Low Enriched Uranium [LEU]. The new state of the art facility in Oak Ridge, TN will incorporate two nuclear reactors and multiple radiopharmaceutical production facilities. See www.coquipharma.com

  • Siemens Healthineers
    • Hospitals and Health Care
    • 700 & Above Employee
    • Chief Executive Officer and President
      • 2010 - 2012

      PETNET Solutions, Inc. designs, manufactures and sells radiopharmaceutical drugs and operates the largest global network. CCS designs, manufactures and sells Cyclotrons and Chemistry Solutions After being headhunted to turn-around Siemens underperforming lines of business, I successfully implemented a new strategic vision, re-engaged customers, and invigorated the culture leading two companies, and 600 employees, with a budget in the hundreds of millions across nine countries, twelve legal entities and four joint ventures. • Initiated transformation program including the launch of a Global Customer Focus Plan. Rationalized unprofitable services and led a refocus on core business and expanded global networks. • Developed a five-year global strategic plan that provided a double digit percentage increase in both gross profit and revenue. Expanded operations globally by opening new manufacturing sites in Spain, France, India and Germany (planned). • Secured a substantial radiopharmaceutical contract in a new Neurological market and a similarly large contract in the existing Oncology market. Similarly, negotiated and acquired new products and manufacturing rights and was first to meet new FDA regulatory requirements.

  • ANSTO
    • Australia
    • Research Services
    • 700 & Above Employee
    • General Manager and Executive Director
      • 2005 - 2010

      ANSTO is Australia's leading manufacturer and supplier of radioisotopes, radiochemicals and radiopharmaceutical products (PET & SPECT) for the nuclear medicine sector. I dynamically led a successful five-year change management program to strategically transition an unprofitable organization with poor reputation, quality practices, delivery metrics, and employee morale into a leading customer focused and profitable organization that sold to 15 countries. I oversaw multiple sites with nuclear reactor, cyclotron and radiochemical/radiopharmaceutical production facilities, a budget of 100% over five years, invested AU$35M to upgrade and automate facilities, and secured AUD$10M in Government funding to open a new commercial PET Radiopharmaceutical subsidiary with state-of-the-art facilities. • Implemented operational and cultural change plans, as well as Quality and Talent Development programs including compliance with required ISO9001, ISO13485, ISO14001, FDA, TGA, ARPANSA, ASNO and IAEA regulations/procedures. Dramatically improved ‘on time’ delivery to 99.9% with historically high customer satisfaction ratings. • Received recognition as a global on authority on Low Enriched Uranium (LEU) SPECT Radiopharmaceuticals.

  • Varian, Inc.
    • Biotechnology Research
    • 200 - 300 Employee
    • Global Business Manager
      • 2003 - 2005

      Varian was a global instrumentation company manufacturing and marketing products for the life science, environmental, and energy markets.I delivered robust profitability two years by transforming the High Performance Liquid Chromatography (HPLC) business unit which operated across six global manufacturing sites and was unprofitable, losing market share, and required urgent strategic redirection. • Prepared and implemented a global strategic plan encompassing operations in the USA, Europe and Australia and included a company-wide product brand recognition program.• Consolidated manufacturing to Australia and negotiated Government financial support, reduced cost of goods sold by 30%, and improved managerial control over production and export.• Delivered improved product control via the implementation of compliance programs, achieving re-certification to ISO9001 and ISO14001 and the creation of specialist Global Centers of Excellence.

    • Global Sales & Marketing Senior Executive/Manager
      • 2000 - 2003

      I oversaw acquisitions, joint ventures, and distribution agreements, with eight managers and 75 globally dispersed employees, as the leader of both the global sales team and the marketing team, we sold and marketed a range of innovative new MRI (Magnetic Resonance Imaging) and NMR (Nuclear Magnetic Resonance) products.• Achieved double-digit growth in first year and played a key role in the doubling of the company share price by delivering a global pricing strategy, a new Sales Team Incentive plan, and OEM distribution agreements.• Led due diligence and acquisition of new organizations, the initiation of strategic partnerships, and the introduction of leading-edge products to the marketplace.

    • Operations Senior Executive/Manager
      • 1999 - 2000

      I led teams spanning Production, Manufacturing Engineering, Facilities, Quality, Environment and Customer Support and implemented Lean Manufacturing methodology across a 200-employee site producing instruments and spares for five spectroscopy and spectrometry product lines.• Oversaw significant commercial improvements by decreasing inventory write-offs and improving just-in-time inventory ordering without impacting delivery schedules.

    • Research and Development Senior Executive/Manager
      • 1996 - 1999

      I assumed increasing responsibility overseeing 110 employees on an AU$8M budget and was instrumental in diversifying revenues via new product lines, introducing new CAD, and delivering across the board efficiencies.• Drastically reduced the company’s new product development cycle from >4 years down to 2 years and received world-wide recognition for scientific innovation and engineering excellence (e.g. IR500 awards).

    • Prior Positions
      • 1988 - 1996

      I gained extensive experience at Varian as Global ICP-AES Product Line Team Manager, Program and Project Manager, Senior Electronic Engineer/Scientist and Electronic/Radio Frequency Engineer (1988–1996).

Education

  • Australian Institute of Company Directors
    Diploma, Corporate Governance & Company Director
    2007 - 2007
  • RMIT University
    Master's Degree, Electronic & Radio Frequency Engineering
    1984 - 1987
  • RMIT University
    Bachelor's Degree, Electronic & Radio Frequency Engineering
    1980 - 1983
  • Monash University
    Diploma*, Business Administration and Management, General
    1995 - 1996

Community

You need to have a working account to view this content. Click here to join now